openPR Logo
Press release

Psoriasis Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033

08-09-2024 06:21 AM CET | Health & Medicine

Press release from: The Business research company

Psoriasis Market

Psoriasis Market

The new report published by The Business Research Company, titled Psoriasis Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the psoriasis market size has grown rapidly in recent years. It will grow from $23.87 billion in 2023 to $26.5 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The psoriasis market size is expected to see rapid growth in the next few years. It will grow to $39.17 billion in 2028 at a compound annual growth rate (CAGR) of 10.3%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=2414&type=smp

Prevalence Of Psoriasis Driving Market Growth
The rise in the prevalence of psoriasis patients is driving the Psoriasis market. Psoriasis is caused due to immune system, genetics, and environment. The rise in psoriasis patients in the past few years can be mainly attributed to climate change, stress, and an unhealthy lifestyle. According to the World Psoriasis Day consortium, 125 million people globally - 2 to 3% of the total population have psoriasis. Therefore, the rise in the prevalence of psoriasis patients is expected to propel the growth of the psoriasis over forecast period.

Combination Therapy Is An Emerging Trend In The Psoriasis Market
Combination therapy is an emerging trend in the psoriasis market. Combination therapy is an f treatment that combines two different psoriasis treatments at the same time. When two drugs with different mechanisms of action are combined (combination therapy), the effect is greater than that obtained by monotherapy (treatment with a single drug). Studies suggest that combination therapy eases psoriasis symptoms more effectively than a single therapy and has lesser side effects. An example of combination therapy for the treatment of active psoriatic arthritis (PsA) is taltz (ixekizumab) with methotrexate developed by Eli Lilly and Company.

The psoriasis market covered in this report is segmented -

1) By Drug class: Interleukin Inhibitors, Corticosteroids, Anti-Inflammatory, Tumor Necrosis Factor Inhibitor
2) By Drug Types: Small molecules, Biologics  
3) By Disease Indication: Plaque Psoriasis, Nail Psoriasis, Guttate Psoriasis, Pustular Psoriasis, Erythrodermic Psoriasis
4) By Route Of Administration: Oral, Tropical, Injectable
5) By Distribution Channel: Hospitals, Retail Pharmacies, E-Commerce

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=2414&type=discount

Major companies operating in the psoriasis market include AbbVie Inc., Pfizer Inc., Novartis AG, Eli Lilly and Company, Celgene Corporation, Johnson & Johnson, Amgen Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Janssen Biotech Inc., Takeda Pharmaceutical Company Limited, Stiefel Laboratories Inc., AstraZeneca Inc., Union Chimique Belge SA, Sun Pharmaceutical Industries Ltd., Forward Pharma AS, Almirall SA, Bausch Health Companies Inc., Biogen Inc., Biocon Biopharmaceuticals Pvt. Ltd., Celltrion Inc., Dr.Reddy's Laboratories Inc., Arcutis Biotherapeutics Inc., Bayer AG, Bristol Myers Squibb Co., Dermira Inc., Galderma SA, GlaxoSmithKline Plc, Incyte Pharmaceuticals Corp., LEO Pharmacy

Contents of the report:
1. Executive Summary
2. Psoriasis Market Report Structure
3. Psoriasis Market Trends And Strategies
4. Psoriasis Market - Macro Economic Scenario
5. Psoriasis Market Size And Growth
…..
27. Psoriasis Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/psoriasis-drugs-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Psoriasis Market 2024 Report By Key Companies, Regional Analysis And Forecast 2033 here

News-ID: 3616551 • Views:

More Releases from The Business research company

Rising Incidence of Dental Disorders Sparks Growth in the Tooth-Filling Material Market: Powering Innovation and Expansion in the Tooth Filling Materials Market by 2025
Rising Incidence of Dental Disorders Sparks Growth in the Tooth-Filling Material …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Tooth Filling Materials Market Through 2025? In the past few years, the market size for tooth filling materials has experienced robust growth. Projected to rise from $1.82 billion in 2024 to $1.92 billion in 2025, it's set to journey at a compound
2025-2034 Stress Tests Equipment Market Outlook: Key Drivers, Emerging Challenges, and Strategic Insights
2025-2034 Stress Tests Equipment Market Outlook: Key Drivers, Emerging Challenge …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Stress Tests Equipment Industry Market Size Be by 2025? In recent years, the market for stress test equipment has seen robust growth. From a value of $2.99 billion in 2024, it is projected to increase to $3.19 billion in 2025, reflecting a compound annual growth rate
2025 Positron Emission Tomography (PET) Scanners Industry Trends Report: Long-Term Outlook Through 2034
2025 Positron Emission Tomography (PET) Scanners Industry Trends Report: Long-Te …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Positron Emission Tomography (PET) Scanners Market Size By 2025? The market size for positron emission tomography (pet) scanners has been witnessing a steady increment in the past years. The market is expected to escalate from $1.51 billion in 2024 to $1.58 billion in 2025, registering
Strategic Forecast for the Ostomy Devices Industry: Market Outlook 2025-2034
Strategic Forecast for the Ostomy Devices Industry: Market Outlook 2025-2034
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Ostomy Devices Market Size Growth Forecast: What to Expect by 2025? In the past few years, the ostomy devices market has been consistently expanding. Projections show an increase from $2.8 billion in 2024 to $2.9 billion in 2025, maintaining a compound annual growth rate (CAGR) of 3.9%. The significant

All 5 Releases


More Releases for Psoriasis

Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psori …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025? Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual
Psoriasis Vulgaris Market
Introduction Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome. The global psoriasis vulgaris
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Psoriasis Market Size During the Forecast Period? The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally. Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It